Fosaprepitant-Induced Phlebitis: A Focus on Patients Receiving Doxorubicin/Cyclophosphamide Therapy

Supportive Care in Cancer - Germany
doi 10.1007/s00520-013-2089-8
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

An Analysis of Fosaprepitant-Induced Venous Toxicity in Patients Receiving Highly Emetogenic Chemotherapy

Supportive Care in Cancer
Oncology
2014English

A Double‐blind, Randomized, Multicenter Phase 3 Study of Palonosetron vs Granisetron Combined With Dexamethasone and Fosaprepitant to Prevent Chemotherapy‐induced Nausea and Vomiting in Patients With Breast Cancer Receiving Anthracycline and Cyclophosphamide

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2020English

Effects of Ozone Therapy on Cyclophosphamide-Induced Urinary Bladder Toxicity in Rats

Clinical and Investigative Medicine
Medicine
2013English

Pharmacogenetics of Toxicity of 5-Fluorouracil, Doxorubicin and Cyclophosphamide Chemotherapy in Breast Cancer Patients

Oncotarget
Oncology
2018English

Cisplatin, Doxorubicin, and Cyclophosphamide Plus Thoracic Radiation Therapy for Limited-Stage Unresectable Thymoma: An Intergroup Trial.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
1997English

Emerging Pharmacotherapies in Ovarian Cancer: Focus on Pegylated Liposomal Doxorubicin

Clinical Medicine Reviews in Women's Health
2010English

Alopecia in Dogs Submitted to a Combined Chemotherapy With Doxorubicin and Cyclophosphamide

Archives of Veterinary Science
Veterinary
2001English

Skin Trauma in Patients Receiving Systemic Corticosteroid Therapy

BMJ
1972English

Factors Impacting on the Action of Glucocorticoids in Patients Receiving Glucocorticoid Therapy

Clinical Endocrinology
EndocrinologyMetabolismDiabetes
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy